This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Allurion Technologies’s 8K filing here.
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
Read More
- Five stocks we like better than Allurion Technologies
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- The 3 Best Blue-Chip Stocks to Buy Now
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- What Are Dividend Achievers? An Introduction
- Micron Technology: Riding the AI Wave to Long-Term Growth
